For instance, in the NSCLC case, we did not identify genetic drivers unique to the most proliferative and disseminating metastatic clade, but we did identify a unique late-to-early ART event in KRAS associated with increased expression. This evidence concerns the gene KRAS and non-small cell lung carcinoma.